- Home
- ALTI vs ATAI Comparison
ALTI vs ATAI Comparison
Compare ALTI & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTI
- ATAI
- Stock Information
- Founded
- ALTI 2020
- ATAI 2018
- Country
- ALTI United States
- ATAI Germany
- Employees
- ALTI N/A
- ATAI N/A
- Industry
- ALTI Investment Managers
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- ALTI Finance
- ATAI Health Care
- Exchange
- ALTI Nasdaq
- ATAI Nasdaq
- Market Cap
- ALTI 317.6M
- ATAI 282.6M
- IPO Year
- ALTI N/A
- ATAI 2021
- Fundamental
- Price
- ALTI $3.33
- ATAI $2.39
- Analyst Decision
- ALTI
- ATAI Strong Buy
- Analyst Count
- ALTI 0
- ATAI 3
- Target Price
- ALTI N/A
- ATAI $10.50
- AVG Volume (30 Days)
- ALTI 84.8K
- ATAI 2.2M
- Earning Date
- ALTI 05-12-2025
- ATAI 05-14-2025
- Dividend Yield
- ALTI N/A
- ATAI N/A
- EPS Growth
- ALTI N/A
- ATAI N/A
- EPS
- ALTI N/A
- ATAI N/A
- Revenue
- ALTI $214,086,000.00
- ATAI $1,863,000.00
- Revenue This Year
- ALTI $24.86
- ATAI $242.21
- Revenue Next Year
- ALTI $10.74
- ATAI N/A
- P/E Ratio
- ALTI N/A
- ATAI N/A
- Revenue Growth
- ALTI N/A
- ATAI 572.56
- 52 Week Low
- ALTI $2.33
- ATAI $1.03
- 52 Week High
- ALTI $5.45
- ATAI $2.57
- Technical
- Relative Strength Index (RSI)
- ALTI 51.28
- ATAI 78.86
- Support Level
- ALTI $3.22
- ATAI $2.18
- Resistance Level
- ALTI $3.46
- ATAI $2.38
- Average True Range (ATR)
- ALTI 0.17
- ATAI 0.19
- MACD
- ALTI -0.01
- ATAI 0.07
- Stochastic Oscillator
- ALTI 31.75
- ATAI 88.09
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.